Agenus shared a post on LinkedIn:
“Agenus and Noetik announced a strategic collaboration to develop predictive biomarkers for BOT/BAL treatment using the power of AI. This partnership leverages Noetik’s proprietary virtual cell foundation models to uncover novel insights from Agenus‘ lead clinical stage immuno-oncology (IO) combination.
Read the full release here.”
More posts featuring Agenus.